{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:21:22Z","timestamp":1789748482944,"version":"4.0.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1006\/gyno.2001.6470","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T22:50:18Z","timestamp":1032303018000},"page":"58-61","source":"Crossref","is-referenced-by-count":11,"title":["Association of CD44 Isoform Immunohistochemical Expression with Myometrial and Vascular Invasion in Endometrioid Endometrial Carcinoma"],"prefix":"10.1006","volume":"84","author":[{"given":"Gary N.","family":"Stokes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.,","given":"Jack B.","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Zahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian S.","family":"Kendall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.2001.6470_RF1","series-title":"Principles and practice of gynecologic oncology","first-page":"859","article-title":"Corpus: epithelial tumors","author":"Barakat","year":"1997"},{"key":"10.1006\/gyno.2001.6470_RF2","first-page":"19","article-title":"Are CD44 variant isoforms involved in human tumour progression?","volume":"24","author":"Gunthert","year":"1995","journal-title":"Cancer Surv"},{"key":"10.1006\/gyno.2001.6470_RF3","doi-asserted-by":"crossref","unstructured":"Sleeman, J, Moll, J, Sherman, L, Dall, P, Pals, S, T, Ponta, H, Herrlich, P, The role of CD44 splice variants in human metastatic cancer. In, Cell adhesion and human disease, New York, Wiley, 1995: 142, \u2013 56, (Ciba Foundation Symposium 189).","DOI":"10.1002\/9780470514719.ch11"},{"key":"10.1006\/gyno.2001.6470_RF4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/gyno.2000.6014","article-title":"Overexpression of CD44 variant 6 in human endometrial cancer and its prognostic significance","volume":"80","author":"Ayhan","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6470_RF5","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/bjc.1998.188","article-title":"The prognostic value of CD44 isoform expression in endometrial cancer","volume":"77","author":"Tempfer","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1006\/gyno.2001.6470_RF6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/gyno.1998.5169","article-title":"Overexpression of CD44 variants 6 and 7 in human endometrial cancer","volume":"71","author":"Katsura","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6470_RF7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0304-3835(97)00517-X","volume":"125","author":"Tokumo","year":"1998","journal-title":"Cancer Lett"},{"key":"10.1006\/gyno.2001.6470_RF8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/(SICI)1096-9896(199803)184:3<297::AID-PATH995>3.0.CO;2-7","article-title":"CD44 expression in normal, hyperplastic, and malignant endometrium","volume":"184","author":"Saegusa","year":"1998","journal-title":"J Pathol"},{"key":"10.1006\/gyno.2001.6470_RF9","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1084\/jem.177.4.897","article-title":"Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44","volume":"177","author":"Koopman","year":"1993","journal-title":"J Exp Med"},{"key":"10.1006\/gyno.2001.6470_RF10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/(SICI)1097-0142(19960715)78:2<273::AID-CNCR13>3.0.CO;2-T","article-title":"Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva","volume":"78","author":"Tempfer","year":"1996","journal-title":"Cancer"},{"key":"10.1006\/gyno.2001.6470_RF11","first-page":"4754","article-title":"Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression","volume":"53","author":"Weilenga","year":"1993","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.2001.6470_RF12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/bjc.1996.364","article-title":"Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer","volume":"74","author":"Gotley","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1006\/gyno.2001.6470_RF13","first-page":"484","article-title":"bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung","volume":"9","author":"Coppola","year":"1996","journal-title":"Mod Pathol"},{"key":"10.1006\/gyno.2001.6470_RF14","first-page":"873","article-title":"Progressive loss of CD44 gene expression in invasive bladder cancer","volume":"149","author":"Sugino","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1006\/gyno.2001.6470_RF15","first-page":"854","article-title":"Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma","volume":"9","author":"Ross","year":"1996","journal-title":"Mod Pathol"},{"key":"10.1006\/gyno.2001.6470_RF16","first-page":"147","article-title":"CD44 exon v6 as a predictor of lymphatic metastases in cervical carcinoma\u2014an immunocytochemical study of 94 cases","volume":"256","author":"Beisold","year":"1995","journal-title":"Arch Gynecol Obstet"},{"key":"10.1006\/gyno.2001.6470_RF17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1006\/gyno.1996.0219","article-title":"Expression of CD44 and variant isoforms in cervical intraepithelial neoplasia","volume":"62","author":"Dellas","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6470_RF18","first-page":"3922","article-title":"Expression of CD44 in normal human versus tumor endometrial tissue: possible implication of reduced expression of CD44 in lymph\u2013vascular space involvement of cancer cells","volume":"54","author":"Fujita","year":"1994","journal-title":"Cancer Research"},{"key":"10.1006\/gyno.2001.6470_RF19","first-page":"194","article-title":"The CD44v6-negative phenotype in high-grade uterine carcinomas correlates with serous histologic subtype","volume":"11","author":"Soslow","year":"1998","journal-title":"Mod Pathol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825801964704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825801964704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T18:40:24Z","timestamp":1576521624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825801964704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S0090825801964704"],"URL":"https:\/\/doi.org\/10.1006\/gyno.2001.6470","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}